Alfresa Holdings Corporation
ARHCFOTCHealthcare● Active
$11.87
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$11.87
52W Low$11.87
Alfresa Holdings Corporation (ARHCF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARHCF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
$0.34
Est. $0.22 · +55.0%
Revenue
$4.67B
Est. $4.64B · +0.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
ARHCF reports quarterly as a OTC-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | — | — | — | — | $4.77B | — |
| ▲ Q2 FY2026 | May 15, 2026 | $0.22 | $0.34 | +55.0% | $4.67B | $4.64B | +0.5% |
| ▲ Q1 FY2026 | Feb 10, 2026 | $0.42 | $0.72 | +71.9% | $5.32B | $5.31B | +0.1% |
| ▼ Q4 FY2025 | Nov 5, 2025 | $0.32 | $0.24 | -25.0% | $5.22B | $4.92B | +5.9% |
| ▼ Q3 FY2025 | Aug 4, 2025 | $0.26 | $0.19 | -25.6% | $5.27B | $5.14B | +2.6% |
| ▼ Q2 FY2025 | May 12, 2025 | $0.20 | $0.06 | -67.9% | $4.80B | $5.22B | -8.0% |
| ▲ Q1 FY2025 | Feb 10, 2025 | $0.30 | $0.40 | +31.7% | $5.13B | $4.92B | +4.1% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.27 | $0.35 | +30.6% | $4.94B | $5.19B | -4.8% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026Beat
EPS Actual
$0.34
EPS Est.
$0.22
EPS Surpr.
+55.0%
Revenue
$4.67B
Q1 FY2026
Feb 10, 2026Beat
EPS Actual
$0.72
EPS Est.
$0.42
EPS Surpr.
+71.9%
Revenue
$5.32B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
$0.24
EPS Est.
$0.32
EPS Surpr.
-25.0%
Revenue
$5.22B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
$0.19
EPS Est.
$0.26
EPS Surpr.
-25.6%
Revenue
$5.27B
Q2 FY2025
May 12, 2025Miss
EPS Actual
$0.06
EPS Est.
$0.20
EPS Surpr.
-67.9%
Revenue
$4.80B
Q1 FY2025
Feb 10, 2025Beat
EPS Actual
$0.40
EPS Est.
$0.30
EPS Surpr.
+31.7%
Revenue
$5.13B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.35
EPS Est.
$0.27
EPS Surpr.
+30.6%
Revenue
$4.94B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $37.62 | $37.62 | $37.62 | 1 |
| Q4 FY2025 | $65.32 | $65.51 | $65.70 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $755B | $755B | $755B | 1 |
| Q4 FY2026 | $846B | $846B | $846B | 1 |
| Q3 FY2026 | $793B | $793B | $793B | 1 |
| Q2 FY2026 | $781B | $781B | $781B | 1 |
| Q1 FY2026 | $738B | $738B | $738B | 1 |
| Q4 FY2025 | $834B | $834B | $834B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 15, 2026 | +55.0% | $11.87 | — | — |
| ▲ Q1 FY2026 | Feb 10, 2026 | +71.9% | $11.87 | $11.87 | +0.00% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -25.0% | $11.87 | $11.87 | +0.00% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -25.6% | $11.87 | $11.87 | +0.00% |
| ▼ Q2 FY2025 | May 12, 2025 | -67.9% | $11.87 | $11.87 | +0.00% |
| ▲ Q1 FY2025 | Feb 10, 2025 | +31.7% | $11.87 | $11.87 | +0.00% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +30.6% | $11.87 | $11.87 | +0.00% |
| ▼ Q3 FY2024 | Aug 5, 2024 | -19.5% | $11.87 | $11.87 | +0.00% |
Q2 FY2026—
Report Date
May 15, 2026
EPS Beat/Miss
+55.0%
Price Before
$11.87
Price After
—
Q1 FY2026+0.00%
Report Date
Feb 10, 2026
EPS Beat/Miss
+71.9%
Price Before
$11.87
Price After
$11.87
Q4 FY2025+0.00%
Report Date
Nov 5, 2025
EPS Beat/Miss
-25.0%
Price Before
$11.87
Price After
$11.87
Q3 FY2025+0.00%
Report Date
Aug 4, 2025
EPS Beat/Miss
-25.6%
Price Before
$11.87
Price After
$11.87
Q2 FY2025+0.00%
Report Date
May 12, 2025
EPS Beat/Miss
-67.9%
Price Before
$11.87
Price After
$11.87
Q1 FY2025+0.00%
Report Date
Feb 10, 2025
EPS Beat/Miss
+31.7%
Price Before
$11.87
Price After
$11.87
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
+30.6%
Price Before
$11.87
Price After
$11.87
Q3 FY2024+0.00%
Report Date
Aug 5, 2024
EPS Beat/Miss
-19.5%
Price Before
$11.87
Price After
$11.87
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARHCF ends December
Alfresa Holdings Corporation (ARHCF) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $0.34 — beating the analyst consensus of $0.22 by +55.0%. ARHCF has beaten EPS estimates for 2 consecutive quarters. The next ARHCF earnings date is expected around September 1, 2026.
Each quarter, investors track ARHCF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARHCF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARHCF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARHCF earnings · 5 questionsAlfresa Holdings Corporation's next earnings report is expected around September 1, 2026. ARHCF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARHCF historically reports after market close (AMC).
ARHCF earnings datewhen is ARHCF earningsARHCF next earnings datewhen does ARHCF report earningsARHCF earnings calendar
▸ Source: FMP · Alfresa Holdings Corporation SEC filings · US GAAP · Alfresa Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026